The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy

NCT00270283 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease

NCT00270010 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy

NCT00270270 ·Status: COMPLETED ·Phase: PHASE2

Treatment Program for Anemia in AIDS Patients

NCT00002022 ·Status: COMPLETED ·Phase: NA

Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity

NCT00744445 ·Status: COMPLETED ·Phase: PHASE2

An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)

NCT00317902 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery

NCT00269958 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer

NCT00269984 ·Status: COMPLETED ·Phase: PHASE2

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

NCT00701714 ·Status: TERMINATED ·Phase: PHASE3

Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia

NCT03528564 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia

NCT00117039 ·Status: COMPLETED ·Phase: PHASE4

Study on Single Administration and Dose Increment of Recombinant Human Serum Albumin/Erythrocyte Fusion Protein for Injection

NCT03786289 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess S303 RBCs and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia

NCT01716923 ·Status: COMPLETED ·Phase: PHASE3

Erythropoietin And/Or Iron Sucrose For Perioperative Anemia Management In Hip and Knee Arthroplasty

NCT03917394 ·Status: UNKNOWN

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

NCT03682536 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Autoantibodies Against Human Recombinant Erythropoietin in Myelodysplatic Syndrome Patients

NCT01548495 ·Status: UNKNOWN

Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course

NCT00180999 ·Status: TERMINATED ·Phase: PHASE3

Hydroxyurea and EPO in Sickle Cell Disease

NCT05451940 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

NCT00144495 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients

NCT00246298 ·Status: TERMINATED ·Phase: PHASE2

Erythropoietin to Improve Critical Care Patient Outcomes

NCT05080049 ·Status: UNKNOWN ·Phase: PHASE3

PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual

NCT01800305 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee.

NCT00270140 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery.

NCT00270062 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin

NCT01628120 ·Status: COMPLETED ·Phase: PHASE3